MDxHealth (MDXH) Receivables - Net (2020 - 2025)
MDxHealth (MDXH) has disclosed Receivables - Net for 6 consecutive years, with $14.7 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 1.63% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.7 million through Dec 2025, up 1.63% year-over-year, with the annual reading at $14.7 million for FY2025, 1.63% up from the prior year.
- Receivables - Net hit $14.7 million in Q4 2025 for MDxHealth, up from $14.4 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $14.7 million in Q4 2025 to a low of $4.6 million in Q4 2021.
- Historically, Receivables - Net has averaged $10.8 million across 5 years, with a median of $11.1 million in 2023.
- Biggest five-year swings in Receivables - Net: skyrocketed 104.21% in 2022 and later grew 1.63% in 2025.
- Year by year, Receivables - Net stood at $4.6 million in 2021, then surged by 104.21% to $9.4 million in 2022, then increased by 18.5% to $11.1 million in 2023, then skyrocketed by 30.23% to $14.4 million in 2024, then rose by 1.63% to $14.7 million in 2025.
- Business Quant data shows Receivables - Net for MDXH at $14.7 million in Q4 2025, $14.4 million in Q4 2024, and $11.1 million in Q4 2023.